id: opioid_marketing_exposure_to_problematic_opioid_use
name: Exposure to Opioid Marketing â†’ Problematic Opioid Use
from_node:
  node_id: opioid_marketing_exposure
  node_name: Exposure to Opioid Marketing
to_node:
  node_id: problematic_opioid_use
  node_name: Problematic Opioid Use
direction: positive
category: social_environment
mechanism_pathway:
- 'Step 1: Pharmaceutical opioid marketing to healthcare providers and consumers normalizes
  opioid prescribing and use'
- 'Step 2: Marketing minimizes addiction risks and emphasizes pain relief benefits,
  shaping prescriber and patient perceptions'
- 'Step 3: Increased prescribing and availability creates population-level exposure
  to addictive substances'
- 'Step 4: Some proportion of exposed individuals develop dependence and problematic
  use patterns'
evidence:
  quality_rating: C
  n_studies: 2
  primary_citation: Anthony Biglan et al. 2019. "A public health framework for the
    regulation of marketing.." *Journal of public health policy*. https://doi.org/10.1057/s41271-018-0154-8
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.271317'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/social_environment/opioid_marketing_exposure_to_problematic_opioid_use.yaml
_category: social_environment
